Physician

Afshin Shahkoohi, MD

According to 2025 Medicare claims, Afshin Shahkoohi, MD (NPI: 1326198631) practices family practice in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is SHAHKOOHI MEDICINE PC (NPI: 1962267666) and primary practice location at 10952-2626.

Shahkoohi's data goes back to 2015 and runs through 2024. Part D data shows 7,059 prescription claims across 453 beneficiaries totaling $851,246 in drug costs, led by Jardiance (Empagliflozin). DME data shows 164 claims. Open Payments data shows 2 records totaling $42. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $242,579 to $851,246. In contrast, DME billing represents a smaller volume and rose steadily, from $2,170 to $16,781.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$566K$1.1M2015 Drug cost: $242,579 (USD; Tot_Drug_Cst)2016 Drug cost: $239,494 (USD; Tot_Drug_Cst)2017 Drug cost: $314,459 (USD; Tot_Drug_Cst)2018 Drug cost: $411,076 (USD; Tot_Drug_Cst)2019 Drug cost: $481,024 (USD; Tot_Drug_Cst)2020 Drug cost: $530,280 (USD; Tot_Drug_Cst)2021 Drug cost: $760,207 (USD; Tot_Drug_Cst)2022 Drug cost: $966,725 (USD; Tot_Drug_Cst)2023 Drug cost: $1,132,574 (USD; Tot_Drug_Cst)2024 Drug cost: $851,246 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152333,702$242,579
20162583,812$239,494
20173214,445$314,459
20183515,192$411,076
20193616,362$481,024
20204186,779$530,280
20214226,379$760,207
20224406,353$966,725
20234617,151$1,132,574
20244537,059$851,246

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$20K$40K2015 Medicare payment: $1,361 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $1,686 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $7,122 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $32,535 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $34,857 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $29,605 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $40,416 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $35,004 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $35,631 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $6,177 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
201519103$1,361
201620145$1,686
201720199$7,122
201819256$32,535
201921303$34,857
202025238$29,605
202139314$40,416
202214290$35,004
202322292$35,631
202419164$6,177

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin2117,870$149,383
Enbrel SureclickEtanercept11330$75,159
MounjaroTirzepatide581,858$67,884
EliquisApixaban933,134$66,756
Metformin Er GastricMetformin Hcl362,280$66,466

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
B4035Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tapeNN/R12$1,521
B4150Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unitNN/R12$1,470
J7520Sirolimus, oral, 1 mgNN/R13$1,226
A7034Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strapNN/R11$512
E0601Continuous positive airway pressure (cpap) deviceYN/R15$436

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$42Lilly USA, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Afshin Shahkoohi, MD?

Tedicare shows public-source Medicare data for Afshin Shahkoohi, MD (NPI 1326198631), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Afshin Shahkoohi, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Afshin Shahkoohi, MD?

Afshin Shahkoohi, MD is linked to SHAHKOOHI MEDICINE PC (billing NPI 1962267666) in the available physician profile data.

Does Afshin Shahkoohi, MD have Open Payments data?

Afshin Shahkoohi, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.